Topical steroid

Apr 30, 2019

FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%

Apr 05, 2019

Advisory - Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks

Feb 13, 2019

Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States

Oct 26, 2018

Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio

Oct 08, 2018

Bausch Health's BRYHALI(TM)(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults

Oct 02, 2018

Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali(TM)* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology

Jul 23, 2018

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus

Apr 25, 2018

Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego

Oct 13, 2017

Focus on psoriasis; Promius Pharma announces 4 posters regarding SERNIVO® (betamethasone dipropionate) Spray, 0.05% at Fall Clinical Dermatology Conference®